efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...

ADROGUÉ, H.J.; MADIAS,N.E. Hyponatremia 2000. N Engl J Méd, Boston, v.342:
p.1581-1589, 2000.
ALBUQUERQUE, C.D. et al. Behalf of acordes trial investigators (ACORDES) Trial –
Brazilian open label study with carvedilol to demonstrate efficacy and chronic heart
failure, including a pilot subgroup with Chagas disease. J Cardiac H Failure,
Philadelphia, v.9;n.5: p.S58, 2003. Abstract.
ALMEIDA, D.R. et al. Fisiologia e tratamento da insuficiência cardíaca. Cardiologia
Intensiva, São Paulo, v.13: p.11-39, 2002.
ANDRADE, Z.A Chagas Disease: Pathology of Chronic Lesions. Revista de Patologia
Tropical; [s.l.], v.31: p.151-160, 2002.
ARAUJO-JORGE, T.C. Resposta imune inata, inflamatória e de fase aguda na
doença de Chagas. Doença de Chagas – Manual de Experimentação Animal, Tânia C
Araujo-Joerge e Solange Lisboa de Castro, Editora Fiocruz, Rio de Janeiro, cap.4.1: p.39-
47, 2000.
ARGENTINA. Ministerio de Salud e Desarrolo. Programa de Salud Humana. Criterios de
diagnostico eletrocardiografico en la cardiopatia chagasica cronica. Buenos Aires.
Programa de Salud Humana, 1p, 1985.
AUKRUST, P. et al. Elevated circulating levels of C-C chemokines in patients with
congestive heart failure. Circulation; Dallas, v.97: p.1136-1143, 1998.
AUKRUST, P. et al. Chemokines in myocardial failure – pathogenic importance and
potential therapeutic targets. Clin Exp Immunol, Philadelphia, v.124: p.343-345, 2001.
BESTETTI, R. et al. Noninvasive predictors of mortality for patients with Chagas' heart
disease: a multivariate stepwise logistic regression study. Cariology, Basel, v.84;n.4-5:
p.261-7, 1994.
BESTETTI, R.B. et al. Predictors of sudden cardiac death for patients with Chagas’
disease: a hospital-derived cohort study. Cardiology, Basel, v.87: p.481-487, 1996.
BESTETTI, R.B.; MUCCILLO, G. Clinical course of Chagas’ heart disease: a
comparasion with dilated cardiomyopathy. Int J Cardiol, Sidney, v.60: p.187-193, 1997.
BESTETTI, R.B. et al. Peripheral and coronary sinus catecholamine levels in patients with
severe congestive heart failure due to Chagas`disease. General Cardiology; New York,
v.86: p.02-206, 1995.
BOGLIOLO, L. As causas anatômicas da insuficiência cardíaca na cardiopatia
(Miocardite) chagásica crônica estudadas comparativamente com as causas anatômicas da
insuficiência cardíaca noutras cardiopatias. Arq Brás Cardiol, São Paulo, v.29;n.5: p.419-
424, 1976.
BORDA, E.S.; STERIN-BORBA, L. Antiadrenergic and muscarinic receptor antibodies in
Chagas’ cardiomyopathy. Int J Cardiol, Sidney, v.54: p.149-156, 1996.
128